Metis Global Partners LLC Has $1.12 Million Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Metis Global Partners LLC lifted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 11.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,557 shares of the real estate investment trust’s stock after acquiring an additional 3,017 shares during the quarter. Metis Global Partners LLC’s holdings in Omega Healthcare Investors were worth $1,119,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. State Street Corp boosted its holdings in shares of Omega Healthcare Investors by 0.9% during the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock valued at $502,228,000 after acquiring an additional 114,085 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Omega Healthcare Investors by 3.1% during the 3rd quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust’s stock valued at $261,589,000 after acquiring an additional 192,465 shares in the last quarter. FMR LLC boosted its holdings in shares of Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock valued at $171,625,000 after acquiring an additional 380,626 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Omega Healthcare Investors by 6.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock valued at $155,893,000 after acquiring an additional 240,006 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

OHI stock opened at $37.61 on Tuesday. The stock has a 50-day moving average price of $37.20 and a 200-day moving average price of $39.03. Omega Healthcare Investors, Inc. has a 1-year low of $29.66 and a 1-year high of $44.42. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02. The firm has a market cap of $10.60 billion, a PE ratio of 24.26, a price-to-earnings-growth ratio of 1.09 and a beta of 0.99.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. As a group, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 7.13%. The ex-dividend date was Monday, February 10th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 172.90%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on OHI shares. Royal Bank of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. JMP Securities reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Mizuho raised their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. Finally, BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price for the company in a research report on Monday, December 9th. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.67.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.